The effect of Ecklonia cava supplement on blood lipid profiles in hyperlipidemic Koreans: a 12‐week, randomized, double‐blind, placebo‐controlled clinical trial (642.7)

This study examined effect and safety of Ecklonia cava supplement on blood lipid metabolism in hyperlipidemic subjects. This study was a 12‐weeks, randomized, double‐blind, placebo‐controlled clinical trial. Inclusion criteria were age of 19 to 80 years and total cholesterol level蠅200mg/dL or LDL‐cholesterol level蠅110mg/dL. Eighty subjects were randomly assigned to two treatment groups: Ecklonia cava (SEPOLYNOL 400mg/day) and placebo group. The...